Flourishing for Peace
Flourishing for Peace Curriculum (Currículo de Florecimiento Para la Paz)
This study is a six-arm individually randomized group-treated (IRGT) trial comparing five16-week standalone flourishing curricula conditions with a control condition consisting of the regular curriculum. Participants will be individually randomized to one of the six conditions. Self-report variables and heart rate variability (HRV) data will be assessed at four time points: T1 (baseline, before the curriculum begins), T2 (8-week midterm), T3 (16-week, at the end of the curriculum), and T4 (beginning of next term), with the main outcome testing changes between T1 and T3. Primary outcomes include the lnRMSSD as a measure of HRV and the overall self-reported flourishing score. Secondary outcomes include 20 domain specific psychological scales and two other HRV measures (SDNN, and mean heart rate). Course-specific knowledge tests will also be administered to gauge participant engagement and course effectiveness. Study results will be reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT) guidelines for non-pharmacological interventions.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Andrea Ortega Bechara
- Phone Number: +573107286975
- Email: a.ortega.bechara@unisinu.edu.co
Study Locations
-
-
-
Montería, Colombia
- Universidad del Sinú (Unisinú)
-
Contact:
- Andrea Ortega Bechara
- Phone Number: +573107286975
- Email: a.ortega.bechara@unisinu.edu.co
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- (a) enrollment as a university student at UniSinu; (b) intention to remain in the campus area for at least 12 months and express a commitment to try to remain engaged in the study from beginning to end; and (c) ability to read, speak, and understand Spanish.
Exclusion Criteria:
- No
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Resilience and Self-Control
This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Resilience and Self-Control |
|
Experimental: Stress, Coping, and Forgiveness
This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Stress, Coping, and Forgiveness |
|
Experimental: Mindfulness and Meaning and Purpose
This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Mindfulness will be taught in 8 of the 16 weeks and Meaning and Purpose will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Mindfulness and Meaning and Purpose |
|
Experimental: Quality of Relationships for Peace and Positive Emotions
This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Quality of Relationships for Peace will be taught in 8 of the 16 weeks and Positive Emotions will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Quality of Relationships for Peace and Positive Emotions |
|
Experimental: Emotional Intelligence, Forgiveness, and Spirituality
This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts. |
Emotional Intelligence, Forgiveness, and Spirituality |
|
Active Comparator: Regular course
Participants assigned to the control condition will continue with their regular university coursework but complete the same measures as the intervention conditions. |
Regular course |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Flourishing: Flourish Measure
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Use the total score across 10 items of the Flourish measure developed by Tyler VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
lnRMSSD
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Heart rate variability (HRV) will be collected using a validated chest-strap sensor ( the Polar H10; Polar Electro, Kempele, Finland) during standardized resting assessments. The natural logarithm of the root mean square of successive differences between normal RR intervals (lnRMSSD), a time-domain measure of short-term heart rate variability and vagal/parasympathetic regulation, will be used as the primary HRV outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Happiness and Life Satisfaction: subscale of Flourish Measure
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Mental and Physical Health: subscale of Flourish Measure
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Meaning and Purpose: subscale of Flourish Measure
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Character and Virtue: subscale of Flourish Measure
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Close Social Relationships: subscale of Flourish Measure
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Depression symptoms: Patient Health Questionnaire-9 (PHQ-9)
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 0 to 3. Higher score indicates more severe depressive symptoms. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Anxiety Symptoms: Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 0 to 3. Higher scores more severe anxiety symptoms. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
The Short Stress Overload Scale
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher stress. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Coherence: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 7. Higher score indicates higher meaning. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Purpose: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 7. Higher score indicates higher meaning. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Significance: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 7. Higher score indicates higher meaning. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Trait Forgivingness Scale
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher forgiveness. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Trait Humility: subscale of Relational Humility Scale
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher humility. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 4. Higher score indicates higher mindfulness. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Brief Self-Control Scale
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher self-control |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Brief Resilience Scale
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher resilience. |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Loneliness: NIH Toolbox Adult Social Relationship Scales
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher level of loneliness |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Transcendent Spirituality: subscale of Trait Sources of Spirituality Scale
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher level of spirituality |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Persevering Hope Scale
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 1 to 5. Higher score indicates higher level of hope |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Coping Self-Efficacy Scale
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Scale score ranges from 0 to 10. Higher score indicates higher level of self-efficacy |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
SDNN
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Standard Deviation of Normal-to-Normal intervals, another HRV measure |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
|
Mean Heart Rate
Time Frame: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Mean Heart Rate |
T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- Acta No. 005 de 2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.